Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
154634333 191994 0 None - 1 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 191994 0 None - 1 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
326869 119588 5 None - 1 Human 9.0 pEC50 = 9.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 119588 5 None - 1 Human 9.0 pEC50 = 9.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
164610101 191654 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 191654 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
12138435 74832 29 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 74832 29 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
70696510 82078 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
CHEMBL2037458 82078 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
70682869 84156 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
CHEMBL2086422 84156 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
5281605 212511 114 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 212511 114 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
145950576 169658 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
CHEMBL4173352 169658 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
70687103 84477 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
CHEMBL2089222 84477 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
70687102 84476 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
CHEMBL2089221 84476 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
5281855 209622 109 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 209622 109 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
53257379 74836 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
CHEMBL1914580 74836 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
135403802 33304 56 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 33304 56 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
411 9371 92 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 9371 92 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 9371 92 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
4488 209800 110 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 209800 110 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
70692387 82085 2 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 259 1 2 2 3.0 Cc1c(C(=O)O)[nH]c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037465 82085 2 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 259 1 2 2 3.0 Cc1c(C(=O)O)[nH]c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
66561718 82082 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037462 82082 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
154634327 191518 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 191518 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
153273978 202705 4 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 202705 4 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 202705 4 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
70681838 82074 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
CHEMBL2037453 82074 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
70689185 84480 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(C(F)(F)F)cc1 10.1021/ml300076u
CHEMBL2089225 84480 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(C(F)(F)F)cc1 10.1021/ml300076u
72103 50182 28 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL150764 50182 28 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634331 191327 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 191327 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145951566 169544 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 169544 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
145951566 169544 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 169544 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
145959592 169129 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4164993 169129 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
411 9371 92 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 9371 92 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 9371 92 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
135399235 10906 60 None -18 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
2919 10906 60 None -18 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
5722 10906 60 None -18 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
CHEMBL28079 10906 60 None -18 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
12533774 192297 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 192297 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
53258793 74845 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914589 74845 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
5281672 63328 121 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 63328 121 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
70694439 82080 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037460 82080 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
154634337 192112 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 192112 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
16103462 74844 19 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 74844 19 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
12138434 74837 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
CHEMBL1914581 74837 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
66561717 82076 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037456 82076 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
135399235 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
135399235 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
2919 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
5722 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
CHEMBL28079 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
70691268 84484 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
CHEMBL2089229 84484 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
135399235 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 10906 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
151577785 193332 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 193332 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
45093111 84481 9 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 208 1 3 4 1.9 Cc1c(C(=O)O)oc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089226 84481 9 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 208 1 3 4 1.9 Cc1c(C(=O)O)oc2cc(O)c(O)cc12 10.1021/ml300076u
154634333 191994 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 191994 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
154634330 192731 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 192731 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634321 192776 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 192776 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
9990345 74840 35 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
CHEMBL1914584 74840 35 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
70697499 84467 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 297 3 3 4 3.1 Cc1ccc(Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
CHEMBL2089195 84467 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 297 3 3 4 3.1 Cc1ccc(Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
110720191 169236 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4166802 169236 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
70692386 82083 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037463 82083 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
16103462 74844 19 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 74844 19 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
73157 202138 30 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 202138 30 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
154634326 191871 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 191871 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
149708825 193170 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 193170 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
53258795 74846 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 74846 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
145959306 169094 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4164556 169094 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
145949189 169516 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 169516 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
2920 9771 103 None 3388 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
54742459 9771 103 None 3388 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
8546 9771 103 None 3388 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
CHEMBL177880 9771 103 None 3388 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
154634332 191906 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 191906 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145949189 169516 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 169516 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
135399235 10906 60 None -18 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
2919 10906 60 None -18 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
5722 10906 60 None -18 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
CHEMBL28079 10906 60 None -18 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
70693381 84472 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 269 2 4 3 2.9 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccccc1 10.1021/ml300076u
CHEMBL2089217 84472 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 269 2 4 3 2.9 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccccc1 10.1021/ml300076u
145958445 168910 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161574 168910 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
152243845 191678 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 191678 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
145955278 169338 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4168406 169338 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
152550147 192107 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 192107 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634334 192204 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 192204 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70681838 82074 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
CHEMBL2037453 82074 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
70687102 84476 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
CHEMBL2089221 84476 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
53258795 74846 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 74846 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
5281605 212511 114 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 212511 114 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
53258796 74847 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914591 74847 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
3715518 36531 7 None -13 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 379 9 1 3 5.2 COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1 nan
CHEMBL1386881 36531 7 None -13 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 379 9 1 3 5.2 COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1 nan
119405 103919 76 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL267855 103919 76 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
150386356 191925 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 191925 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
119405 103919 76 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL267855 103919 76 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
73157 202138 30 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 202138 30 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
152684818 191771 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 191771 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
66561718 82082 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037462 82082 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
70687103 84477 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
CHEMBL2089222 84477 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
66561717 82076 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037456 82076 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
70695483 84473 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
CHEMBL2089218 84473 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
70689184 84475 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
CHEMBL2089220 84475 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
154634327 191518 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 191518 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
154634326 191871 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 191871 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70691267 84479 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(Cl)cc1 10.1021/ml300076u
CHEMBL2089224 84479 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(Cl)cc1 10.1021/ml300076u
944642 65894 11 None -30 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 324 5 2 4 4.2 CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1 nan
CHEMBL1698243 65894 11 None -30 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 324 5 2 4 4.2 CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1 nan
70692386 82083 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037463 82083 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
70690212 82079 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 302 2 1 3 4.3 O=C(O)c1sc2c(Br)csc2c1C1CC1 10.1016/j.bmcl.2012.04.057
CHEMBL2037459 82079 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 302 2 1 3 4.3 O=C(O)c1sc2c(Br)csc2c1C1CC1 10.1016/j.bmcl.2012.04.057
66561793 82086 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037466 82086 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
150149078 193123 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 193123 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
3884 51272 77 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 51272 77 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
152727536 191266 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 191266 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634322 192159 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 192159 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
5281855 209622 109 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 209622 109 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
57134579 169411 18 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4169520 169411 18 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145957901 168854 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 168854 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145957901 168854 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 168854 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
5281672 63328 121 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 63328 121 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
145951357 169543 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 169543 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
154634320 193389 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 193389 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
70683937 81816 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
CHEMBL2035007 81816 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
145951357 169543 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 169543 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
12138435 74832 29 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 74832 29 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
5215 9165 132 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 9165 132 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 9165 132 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
154634315 191657 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852718 191657 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
56646802 74833 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
CHEMBL1914577 74833 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
135399235 10906 60 None -18 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 10906 60 None -18 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 10906 60 None -18 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 10906 60 None -18 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
16103482 74841 1 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
CHEMBL1914585 74841 1 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
70695483 84473 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
CHEMBL2089218 84473 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
145971743 169883 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 169883 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
145971743 169883 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 169883 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
11674067 74834 28 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
CHEMBL1914578 74834 28 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
145953959 169456 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4170205 169456 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
70686064 82075 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037454 82075 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
154634324 192490 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 192490 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70686065 82084 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037464 82084 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
145971240 169866 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 169866 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145971240 169866 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 169866 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
5491415 82067 19 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 82067 19 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
154634318 192778 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 192778 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
70696510 82078 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
CHEMBL2037458 82078 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
2918 8985 126 None -2630 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
3845 8985 126 None -2630 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
CHEMBL299155 8985 126 None -2630 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
DB11937 8985 126 None -2630 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
70691265 84469 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 325 4 3 5 2.9 Cc1ccc(C(=O)Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
CHEMBL2089197 84469 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 325 4 3 5 2.9 Cc1ccc(C(=O)Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
4488 209800 110 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 209800 110 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
145956623 168792 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 168792 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
145956623 168792 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 168792 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
70682865 84470 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 1 4 3 2.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1Br 10.1021/ml300076u
CHEMBL2089199 84470 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 1 4 3 2.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1Br 10.1021/ml300076u
135399235 10906 60 None -18 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 10906 60 None -18 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 10906 60 None -18 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 10906 60 None -18 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
660319 17775 96 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
CHEMBL1173787 17775 96 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
68324914 192510 38 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 192510 38 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
13950957 164107 7 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 164107 7 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
15774808 84466 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 283 3 3 4 2.8 O=C(O)c1cc2cc(O)c(O)cc2n1Cc1ccccc1 10.1021/ml300076u
CHEMBL2089194 84466 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 283 3 3 4 2.8 O=C(O)c1cc2cc(O)c(O)cc2n1Cc1ccccc1 10.1021/ml300076u
145958495 168977 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 168977 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
70687104 84478 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 305 2 4 3 3.2 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(F)cc(F)c1 10.1021/ml300076u
CHEMBL2089223 84478 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 305 2 4 3 3.2 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(F)cc(F)c1 10.1021/ml300076u
70689180 84468 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 311 4 3 5 2.6 O=C(Cn1c(C(=O)O)cc2cc(O)c(O)cc21)c1ccccc1 10.1021/ml300076u
CHEMBL2089196 84468 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 311 4 3 5 2.6 O=C(Cn1c(C(=O)O)cc2cc(O)c(O)cc21)c1ccccc1 10.1021/ml300076u
145958495 168977 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 168977 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
10868388 168912 47 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161599 168912 47 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145954149 169378 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 169378 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
154634323 191383 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 191383 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145954149 169378 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 169378 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
15774807 84464 31 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089192 84464 31 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
53258898 74848 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914592 74848 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
70697498 84465 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089193 84465 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
21337669 74838 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
CHEMBL1914582 74838 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
145952561 169738 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4174783 169738 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
70691268 84484 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
CHEMBL2089229 84484 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
135403802 33304 56 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 33304 56 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
3884 51272 77 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 51272 77 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
154634328 191880 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 191880 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164627011 193185 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 193185 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
2920 9771 103 None 3388 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
54742459 9771 103 None 3388 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
8546 9771 103 None 3388 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
CHEMBL177880 9771 103 None 3388 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
6619478 32709 3 None -9 2 Human 6.3 pEC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
CHEMBL1354041 32709 3 None -9 2 Human 6.3 pEC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
70683937 81816 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
CHEMBL2035007 81816 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
145955027 169319 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 169319 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
145955027 169319 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 169319 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
5491415 82067 19 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 82067 19 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
44351698 127626 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
CHEMBL3558475 127626 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
145958540 169049 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 169049 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
6622007 45816 7 None -9 4 Human 5.3 pEC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
CHEMBL1468612 45816 7 None -9 4 Human 5.3 pEC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
145958540 169049 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 169049 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
70683939 82081 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037461 82081 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70686065 82084 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037464 82084 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
70690213 82088 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037468 82088 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
135399235 10906 60 None -18 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
2919 10906 60 None -18 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
5722 10906 60 None -18 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
CHEMBL28079 10906 60 None -18 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
21337671 74839 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
CHEMBL1914583 74839 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
153273978 202705 4 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 202705 4 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 202705 4 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
164627011 193185 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 193185 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
70694439 82080 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037460 82080 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
145971442 169806 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 169806 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145971442 169806 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 169806 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
5280343 195054 124 None -8 12 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 195054 124 None -8 12 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 195054 124 None -8 12 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
154634332 191906 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 191906 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
16103465 74843 2 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914587 74843 2 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
16103462 74844 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL1914588 74844 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
145952912 169223 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 169223 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
135399235 10906 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 10906 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 10906 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 10906 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
70682869 84156 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
CHEMBL2086422 84156 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
145954727 169200 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 169200 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145952912 169223 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 169223 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
70684936 84483 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089228 84483 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
135399235 10906 60 None -18 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 10906 60 None -18 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 10906 60 None -18 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 10906 60 None -18 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
154634321 192776 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 192776 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145954727 169200 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 169200 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
135399235 10906 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
2919 10906 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
5722 10906 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
CHEMBL28079 10906 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
66561793 82086 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037466 82086 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
16103462 74844 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 74844 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
16103462 74844 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 74844 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
15774807 84464 31 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089192 84464 31 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
45489602 66049 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 66049 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
154634336 192847 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 192847 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
45489602 66049 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 66049 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
21337670 74835 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
CHEMBL1914579 74835 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
70686064 82075 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037454 82075 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
44351698 127626 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
CHEMBL3558475 127626 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
5328791 211763 64 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 211763 64 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
1024 23260 106 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 23260 106 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
5215 9165 132 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 9165 132 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 9165 132 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
20259231 84482 18 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 210 1 3 4 2.0 O=C(O)c1cc2cc(O)c(O)cc2s1 10.1021/ml300076u
CHEMBL2089227 84482 18 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 210 1 3 4 2.0 O=C(O)c1cc2cc(O)c(O)cc2s1 10.1021/ml300076u
70689184 84475 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
CHEMBL2089220 84475 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
70697498 84465 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089193 84465 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
326869 119588 5 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 119588 5 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
164610101 191654 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 191654 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
5280343 195054 124 None -8 12 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 195054 124 None -8 12 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 195054 124 None -8 12 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
154634314 193388 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 193388 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145953203 169317 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 169317 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
16103462 74844 19 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL1914588 74844 19 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
145953203 169317 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 169317 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
70681839 82087 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 221 2 2 2 3.1 Cc1c(C(=O)O)[nH]c2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037467 82087 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 221 2 2 2 3.1 Cc1c(C(=O)O)[nH]c2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70689183 84474 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 270 2 4 4 2.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccnc1 10.1021/ml300076u
CHEMBL2089219 84474 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 270 2 4 4 2.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccnc1 10.1021/ml300076u
145952039 169587 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 169587 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145952039 169587 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 169587 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145974046 169791 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 169791 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
151271218 192934 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 192934 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
145959908 168841 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 168841 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
145952453 169567 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 169567 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
145959908 168841 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 168841 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
145952453 169567 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 169567 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
145974046 169791 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 169791 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
70690213 82088 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037468 82088 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
70684936 84483 0 None - 1 Human 4.0 pEC50 = 4.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089228 84483 0 None - 1 Human 4.0 pEC50 = 4.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
154634335 191262 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 191262 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
154634316 193121 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 193121 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
53258899 74842 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914586 74842 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
57697 21238 38 None - 1 Rat 7.0 pEC50 = 7.0 Functional
Agonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assayAgonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assay
ChEMBL 228 1 1 6 0.2 Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12 10.1021/acsmedchemlett.7b00510
CHEMBL1201198 21238 38 None - 1 Rat 7.0 pEC50 = 7.0 Functional
Agonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assayAgonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assay
ChEMBL 228 1 1 6 0.2 Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12 10.1021/acsmedchemlett.7b00510
70683939 82081 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037461 82081 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70683938 82077 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 200 1 2 4 2.4 O=C(O)c1sc2ccsc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037457 82077 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 200 1 2 4 2.4 O=C(O)c1sc2ccsc2c1O 10.1016/j.bmcl.2012.04.057
5328791 211763 64 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 211763 64 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
154634333 191994 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 191994 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
326869 119588 5 None - 1 Human 9.1 pIC50 = 9.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 119588 5 None - 1 Human 9.1 pIC50 = 9.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634333 191994 0 None - 1 Human 8.0 pIC50 = 8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 191994 0 None - 1 Human 8.0 pIC50 = 8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
3110120 48692 10 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 10 3 5 5.2 CCCCCOC(=O)c1ccc(NC(=O)c2cccc(NC(=O)c3ccccc3C(=O)O)c2)cc1 nan
CHEMBL1494365 48692 10 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 10 3 5 5.2 CCCCCOC(=O)c1ccc(NC(=O)c2cccc(NC(=O)c3ccccc3C(=O)O)c2)cc1 nan
644413 40305 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 315 1 1 5 2.0 CN1C=CC2=C(C#N)C(N)C(C#N)(C#N)C(c3ccccc3)C2C1 nan
CHEMBL1420573 40305 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 315 1 1 5 2.0 CN1C=CC2=C(C#N)C(N)C(C#N)(C#N)C(c3ccccc3)C2C1 nan
9581006 66162 2 None 12 3 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 379 5 2 6 3.0 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709028 66162 2 None 12 3 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 379 5 2 6 3.0 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccccc1 nan
18296 76637 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
5351211 76637 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
5474842 76637 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
6326610 76637 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
CHEMBL193872 76637 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
CHEMBL466853 76637 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
152550147 192107 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 192107 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634315 191657 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852718 191657 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
53257379 74836 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
CHEMBL1914580 74836 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
53258793 74845 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914589 74845 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
135399235 10906 60 None -18 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 10906 60 None -18 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 10906 60 None -18 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 10906 60 None -18 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
151271218 192934 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 192934 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
4811966 50463 6 None 2 5 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 4 1 4 3.3 CC(NC(=O)Cn1ncc(Cl)c(Cl)c1=O)C12CC3CC(CC(C3)C1)C2 nan
CHEMBL1510156 50463 6 None 2 5 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 4 1 4 3.3 CC(NC(=O)Cn1ncc(Cl)c(Cl)c1=O)C12CC3CC(CC(C3)C1)C2 nan
16103462 74844 19 None - 1 Human 7.0 pIC50 = 7.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 74844 19 None - 1 Human 7.0 pIC50 = 7.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
145957901 168854 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 168854 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145951357 169543 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 169543 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
5602180 62280 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
CHEMBL1416442 62280 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
CHEMBL1620242 62280 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
16195500 48505 9 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
CHEMBL1492565 48505 9 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
9581008 66320 4 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 66320 4 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
150386356 191925 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 191925 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
2963825 54476 10 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 382 4 1 6 4.4 O=C(Nc1nc2ccccc2s1)c1ccc(N2CCCCC2)c([N+](=O)[O-])c1 nan
CHEMBL1547464 54476 10 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 382 4 1 6 4.4 O=C(Nc1nc2ccccc2s1)c1ccc(N2CCCCC2)c([N+](=O)[O-])c1 nan
2259994 48180 8 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 262 2 0 4 1.9 CN1C(=O)/C(=C\c2ccc(N(C)C)cc2)OC1=S nan
CHEMBL1490312 48180 8 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 262 2 0 4 1.9 CN1C(=O)/C(=C\c2ccc(N(C)C)cc2)OC1=S nan
135549592 115219 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 369 7 4 6 1.4 COc1ccc(/C=C\C(=O)NCC(=O)N/N=C/c2ccc(O)cc2O)cc1 nan
CHEMBL3198952 115219 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 369 7 4 6 1.4 COc1ccc(/C=C\C(=O)NCC(=O)N/N=C/c2ccc(O)cc2O)cc1 nan
1416931 30190 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1333032 30190 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
1348328 38560 7 None 16 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C/C=C/c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1406190 38560 7 None 16 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C/C=C/c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
5334489 52738 7 None 10 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 7 1 4 5.3 CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)c(OC(C)C)c1 nan
CHEMBL1532412 52738 7 None 10 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 7 1 4 5.3 CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)c(OC(C)C)c1 nan
4137407 36585 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 3 1 7 4.6 Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
CHEMBL1387336 36585 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 3 1 7 4.6 Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
152684818 191771 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 191771 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
5733585 47744 10 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
CHEMBL1487024 47744 10 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
655684 47863 8 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 1 1 5 3.3 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3cccc(Cl)c3Cl)C2C1 nan
CHEMBL1487918 47863 8 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 1 1 5 3.3 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3cccc(Cl)c3Cl)C2C1 nan
9990345 74840 35 None - 1 Human 4.9 pIC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
CHEMBL1914584 74840 35 None - 1 Human 4.9 pIC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
135399235 10906 60 None -18 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 10906 60 None -18 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 10906 60 None -18 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 10906 60 None -18 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
6484583 44010 4 None -89 3 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]
ChEMBL 410 5 1 5 2.6 COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1 nan
CHEMBL1453578 44010 4 None -89 3 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]
ChEMBL 410 5 1 5 2.6 COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1 nan
9581013 66484 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
CHEMBL1723578 66484 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
1348329 33020 12 None 3 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1357976 33020 12 None 3 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
145952561 169738 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4174783 169738 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
13950957 164107 7 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 164107 7 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
2961024 51705 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 452 8 2 4 5.7 CCOc1ccc(NC(=O)C(C)Oc2ccccc2C(=O)Nc2ccc(C)c(Cl)c2)cc1 nan
CHEMBL1523126 51705 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 452 8 2 4 5.7 CCOc1ccc(NC(=O)C(C)Oc2ccccc2C(=O)Nc2ccc(C)c(Cl)c2)cc1 nan
149708825 193170 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 193170 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
24792210 61965 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1351967 61965 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1617564 61965 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
145953959 169456 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4170205 169456 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
72652 41622 62 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 309 0 0 3 3.5 O=c1cc(C(F)(F)F)c2cc3c4c(c2o1)CCCN4CCC3 nan
CHEMBL1431610 41622 62 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 309 0 0 3 3.5 O=c1cc(C(F)(F)F)c2cc3c4c(c2o1)CCCN4CCC3 nan
151577785 193332 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 193332 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
135475176 114801 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
135517099 114801 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
CHEMBL3194571 114801 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
2745687 7720 31 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
9741 7720 31 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
CHEMBL1708510 7720 31 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
1346721 36592 11 None 1 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 440 7 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1 nan
CHEMBL1387413 36592 11 None 1 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 440 7 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1 nan
145956623 168792 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 168792 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
3153499 39350 18 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 344 3 0 5 2.5 CS(=O)(=O)N1N=C(c2ccccc2)CC1c1ccc2c(c1)OCO2 nan
CHEMBL1412529 39350 18 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 344 3 0 5 2.5 CS(=O)(=O)N1N=C(c2ccccc2)CC1c1ccc2c(c1)OCO2 nan
16196320 61833 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
3394229 61833 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
5813410 61833 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
CHEMBL1308547 61833 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
CHEMBL1616589 61833 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
1382708 36637 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1387749 36637 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
4362054 32863 7 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 495 9 2 8 4.3 CCOc1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1355774 32863 7 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 495 9 2 8 4.3 CCOc1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
152727536 191266 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 191266 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
24761764 59587 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 5 1 3 4.3 CC(NS(=O)(=O)OCC(Cl)(Cl)Cl)c1ccc(C(C)(C)C)cc1 nan
CHEMBL1595152 59587 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 5 1 3 4.3 CC(NS(=O)(=O)OCC(Cl)(Cl)Cl)c1ccc(C(C)(C)C)cc1 nan
16103482 74841 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
CHEMBL1914585 74841 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
6518655 115584 7 None 2 3 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 528 7 1 7 5.5 COc1ccc(/N=C2\S/C(=C\c3ccc(N4CCOCC4)o3)C(=O)N2CCc2c[nH]c3ccccc23)cc1 nan
CHEMBL3209511 115584 7 None 2 3 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 528 7 1 7 5.5 COc1ccc(/N=C2\S/C(=C\c3ccc(N4CCOCC4)o3)C(=O)N2CCc2c[nH]c3ccccc23)cc1 nan
154634327 191518 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 191518 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
154634324 192490 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 192490 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164627011 193185 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 193185 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
154634326 191871 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 191871 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
150386356 191925 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 191925 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
1382708 36637 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1387749 36637 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
2885134 51213 8 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 373 6 2 5 5.0 CCOc1ccc2nc3cc(NCc4ccc(OC)cc4)ccc3c(N)c2c1 nan
CHEMBL1518827 51213 8 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 373 6 2 5 5.0 CCOc1ccc2nc3cc(NCc4ccc(OC)cc4)ccc3c(N)c2c1 nan
45917986 66129 7 None -6 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 314 2 0 4 4.4 Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1 nan
CHEMBL1707517 66129 7 None -6 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 314 2 0 4 4.4 Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1 nan
2286888 47854 10 None 11 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 466 8 2 5 5.0 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)cc2)C1=O)=C\c1ccccc1 nan
CHEMBL1487870 47854 10 None 11 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 466 8 2 5 5.0 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)cc2)C1=O)=C\c1ccccc1 nan
2247463 34366 9 None 15 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 515 8 3 7 4.6 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(C(C)C)cc3)cc2)s1 nan
CHEMBL1369492 34366 9 None 15 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 515 8 3 7 4.6 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(C(C)C)cc3)cc2)s1 nan
154634328 191880 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 191880 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
152727536 191266 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 191266 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
145954149 169378 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 169378 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
2745687 7720 31 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
9741 7720 31 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
CHEMBL1708510 7720 31 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
8072340 62616 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
CHEMBL1517609 62616 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
CHEMBL1623159 62616 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
1205881 42939 5 None 23 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1444708 42939 5 None 23 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
21337669 74838 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
CHEMBL1914582 74838 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
1231538 34291 29 None -1 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1368962 34291 29 None -1 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
3596034 49103 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 308 2 0 4 3.0 CCN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
CHEMBL1498210 49103 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 308 2 0 4 3.0 CCN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
9581010 65954 4 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1700467 65954 4 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
154634337 192112 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 192112 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
145971743 169883 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 169883 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
9581010 65954 4 None - 1 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1700467 65954 4 None - 1 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
152684818 191771 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 191771 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
21157241 78656 5 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 381 5 1 5 2.3 COc1ccc(/C=c2\s/c(=C/C(=O)c3ccc(C)cc3)[nH]c2=O)c(OC)c1 nan
CHEMBL1970711 78656 5 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 381 5 1 5 2.3 COc1ccc(/C=c2\s/c(=C/C(=O)c3ccc(C)cc3)[nH]c2=O)c(OC)c1 nan
1502520 41275 21 None -9 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
CHEMBL1428840 41275 21 None -9 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
15945506 54795 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 5 1 4 5.8 CC(=O)c1ccc(NC(=O)C(C)n2nc(-c3ccccc3)c3cc(Cl)ccc32)cc1 nan
CHEMBL1550295 54795 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 5 1 4 5.8 CC(=O)c1ccc(NC(=O)C(C)n2nc(-c3ccccc3)c3cc(Cl)ccc32)cc1 nan
154634326 191871 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 191871 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634321 192776 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 192776 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
152243845 191678 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 191678 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
2770749 62803 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
5708223 62803 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
5830170 62803 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
CHEMBL1572785 62803 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
CHEMBL1624721 62803 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
53258796 74847 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914591 74847 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
2277094 55790 10 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1560901 55790 10 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
11674067 74834 28 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
CHEMBL1914578 74834 28 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
2526579 61541 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 423 12 1 7 5.0 CCN(CC)CCCNc1ccc(-c2nnc(-c3ccc(OCC(C)C)cc3)o2)cn1 nan
CHEMBL1612267 61541 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 423 12 1 7 5.0 CCN(CC)CCCNc1ccc(-c2nnc(-c3ccc(OCC(C)C)cc3)o2)cn1 nan
6489901 62937 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
CHEMBL1576905 62937 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
CHEMBL1626041 62937 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
326869 119588 5 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 119588 5 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634321 192776 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 192776 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634332 191906 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 191906 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
68324914 192510 38 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 192510 38 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
154634328 191880 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 191880 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145958495 168977 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 168977 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
150149078 193123 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 193123 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
5144920 28120 3 None 1 2 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 424 3 1 7 4.3 Cc1c(C(=O)Nc2ccc3c(c2)OCCO3)sc2ncnc(N3CCC(C)CC3)c12 nan
CHEMBL1314099 28120 3 None 1 2 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 424 3 1 7 4.3 Cc1c(C(=O)Nc2ccc3c(c2)OCCO3)sc2ncnc(N3CCC(C)CC3)c12 nan
4557537 44872 4 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 424 3 1 7 4.3 Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
CHEMBL1460894 44872 4 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 424 3 1 7 4.3 Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
6203183 59126 8 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 7 3 8 3.4 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
CHEMBL1589711 59126 8 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 7 3 8 3.4 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
6876400 79764 5 None 3 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 8 2 6 5.0 CCOc1ccc(/C=N/NC(=O)Cc2csc(Nc3cccc(C(F)(F)F)c3)n2)cc1 nan
CHEMBL2007593 79764 5 None 3 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 8 2 6 5.0 CCOc1ccc(/C=N/NC(=O)Cc2csc(Nc3cccc(C(F)(F)F)c3)n2)cc1 nan
154634324 192490 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 192490 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145958540 169049 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 169049 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
145952912 169223 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 169223 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
9581015 66173 4 None - 1 Human 6.7 pIC50 = 6.7 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709632 66173 4 None - 1 Human 6.7 pIC50 = 6.7 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
3243122 53178 7 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 421 3 0 5 4.6 COc1ccc2nc3oc(C(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3cc2c1 nan
CHEMBL1536710 53178 7 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 421 3 0 5 4.6 COc1ccc2nc3oc(C(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3cc2c1 nan
5731274 59124 9 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 468 8 1 6 4.8 CCOC(=O)c1ccc(NC(=O)CCCN2C(=O)/C(=C/c3ccc(C)cc3)SC2=S)cc1 nan
CHEMBL1589694 59124 9 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 468 8 1 6 4.8 CCOC(=O)c1ccc(NC(=O)CCCN2C(=O)/C(=C/c3ccc(C)cc3)SC2=S)cc1 nan
21337670 74835 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
CHEMBL1914579 74835 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
8108341 44403 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 364 7 1 3 5.1 O=C(O)COc1ccc(/C=C/C(=O)c2ccc(C3CCCCC3)cc2)cc1 nan
CHEMBL1457048 44403 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 364 7 1 3 5.1 O=C(O)COc1ccc(/C=C/C(=O)c2ccc(C3CCCCC3)cc2)cc1 nan
720233 56965 39 None 2 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 288 2 0 3 3.3 O=c1c(Cl)c(Cl)cnn1Cc1ccccc1Cl nan
CHEMBL1570760 56965 39 None 2 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 288 2 0 3 3.3 O=c1c(Cl)c(Cl)cnn1Cc1ccccc1Cl nan
9581015 66173 4 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709632 66173 4 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
154634314 193388 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 193388 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
3420390 185389 5 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 8 2 5 1.6 NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1 nan
CHEMBL467373 185389 5 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 8 2 5 1.6 NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1 nan
151577785 193332 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 193332 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
5513575 49501 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
CHEMBL1501743 49501 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
9581008 66320 4 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 66320 4 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
4623233 66821 7 None -12 3 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 320 2 0 4 4.4 Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12 nan
CHEMBL1736438 66821 7 None -12 3 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 320 2 0 4 4.4 Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12 nan
16193843 52853 6 None - 1 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 3 1 7 3.8 CC(C)CSC1=NSC2=NC(=O)/C(=C\c3coc4ccccc4c3=O)C(=N)N12 nan
CHEMBL1533415 52853 6 None - 1 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 3 1 7 3.8 CC(C)CSC1=NSC2=NC(=O)/C(=C\c3coc4ccccc4c3=O)C(=N)N12 nan
2286812 36239 35 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 nan
CHEMBL1384502 36239 35 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 nan
5768597 27543 6 None 3 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 320 3 1 5 3.1 N#C/C(=C/c1ccc(N2CCOCC2)o1)c1nc2ccccc2[nH]1 nan
CHEMBL1309475 27543 6 None 3 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 320 3 1 5 3.1 N#C/C(=C/c1ccc(N2CCOCC2)o1)c1nc2ccccc2[nH]1 nan
12005127 51580 4 None -3 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 333 6 0 4 4.6 COc1cc(/C=C(/C)[N+](=O)[O-])ccc1OCc1ccccc1Cl nan
CHEMBL1521989 51580 4 None -3 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 333 6 0 4 4.6 COc1cc(/C=C(/C)[N+](=O)[O-])ccc1OCc1ccccc1Cl nan
9581008 66320 4 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 66320 4 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
154634318 192778 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 192778 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
164627011 193185 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 193185 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
1346847 27973 8 None - 1 Human 6.6 pIC50 = 6.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
CHEMBL1312928 27973 8 None - 1 Human 6.6 pIC50 = 6.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
154634322 192159 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 192159 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
6109309 36754 3 None 3 3 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 355 5 1 4 4.0 CC(NC(=O)/C(C#N)=C/c1ccc(Cl)c([N+](=O)[O-])c1)c1ccccc1 nan
CHEMBL1388639 36754 3 None 3 3 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 355 5 1 4 4.0 CC(NC(=O)/C(C#N)=C/c1ccc(Cl)c([N+](=O)[O-])c1)c1ccccc1 nan
6622007 45816 7 None -9 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
CHEMBL1468612 45816 7 None -9 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
4798059 38699 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 296 4 1 3 4.3 COc1ccc2nc(C)cc(NCc3ccc(F)cc3)c2c1 nan
CHEMBL1407436 38699 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 296 4 1 3 4.3 COc1ccc2nc(C)cc(NCc3ccc(F)cc3)c2c1 nan
154634335 191262 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 191262 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
154634323 191383 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 191383 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145971442 169806 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 169806 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145953203 169317 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 169317 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
145955027 169319 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 169319 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
6226024 52443 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 442 7 3 6 3.7 O=C(CCCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
CHEMBL1529781 52443 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 442 7 3 6 3.7 O=C(CCCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
154634336 192847 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 192847 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634316 193121 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 193121 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
759209 42745 10 None -1 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 259 1 0 3 3.5 Cc1c(Cl)sn(-c2ccc(Cl)cc2)c1=O nan
CHEMBL1442788 42745 10 None -1 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 259 1 0 3 3.5 Cc1c(Cl)sn(-c2ccc(Cl)cc2)c1=O nan
648447 45574 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 3 1 7 2.1 COc1cccc(C2C3CN(C)CC=C3C(C#N)=C(N)C2(C#N)C#N)c1OC nan
CHEMBL1466582 45574 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 3 1 7 2.1 COc1cccc(C2C3CN(C)CC=C3C(C#N)=C(N)C2(C#N)C#N)c1OC nan
1527596 49862 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 7 2 7 4.9 CCOC(=O)c1c(-c2ccccc2)csc1NC(=O)/C(C#N)=C/c1ccc(O)c(OC)c1 nan
CHEMBL1504949 49862 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 7 2 7 4.9 CCOC(=O)c1c(-c2ccccc2)csc1NC(=O)/C(C#N)=C/c1ccc(O)c(OC)c1 nan
4406525 45208 5 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 294 1 0 4 2.6 CN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
CHEMBL1463795 45208 5 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 294 1 0 4 2.6 CN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
45489602 66049 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 66049 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
145971240 169866 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 169866 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
164610101 191654 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 191654 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
1214651 66348 9 None -42 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 414 2 0 4 5.7 Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12 nan
CHEMBL1718220 66348 9 None -42 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 414 2 0 4 5.7 Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12 nan
154634327 191518 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 191518 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
6619478 32709 3 None -9 2 Human 4.5 pIC50 = 4.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
CHEMBL1354041 32709 3 None -9 2 Human 4.5 pIC50 = 4.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
154634337 192112 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 192112 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
164627011 193185 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 193185 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
1024 23260 106 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 23260 106 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
154634320 193389 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 193389 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
154634331 191327 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 191327 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145952453 169567 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 169567 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
14286542 78995 3 None -4 4 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 401 2 3 4 2.9 CC1=CC2/C=C(\C)CCC(O)C(O)/C=C/C(=O)C23C(=O)NC(CC(C)C)C3C1C nan
CHEMBL1981103 78995 3 None -4 4 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 401 2 3 4 2.9 CC1=CC2/C=C(\C)CCC(O)C(O)/C=C/C(=O)C23C(=O)NC(CC(C)C)C3C1C nan
9581005 66405 2 None 21 2 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 359 4 2 6 2.3 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)NC(C)(C)C nan
CHEMBL1720530 66405 2 None 21 2 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 359 4 2 6 2.3 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)NC(C)(C)C nan
135650717 114989 5 None -2 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 4 3 6 4.3 Oc1ccc(/C=N/Nc2nc(-c3ccccc3F)nc3ccccc23)c(O)c1 nan
CHEMBL3196703 114989 5 None -2 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 4 3 6 4.3 Oc1ccc(/C=N/Nc2nc(-c3ccccc3F)nc3ccccc23)c(O)c1 nan
6226345 37918 8 None 4 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 5 3 4 2.9 CCCCN1C(=O)NC(=O)/C(=C(O)\C=C\c2c[nH]c3ccccc23)C1=O nan
CHEMBL1400236 37918 8 None 4 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 5 3 4 2.9 CCCCN1C(=O)NC(=O)/C(=C(O)\C=C\c2c[nH]c3ccccc23)C1=O nan
2868490 61091 11 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 3 0 3 5.6 COc1ccc(C=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)cc1OC nan
CHEMBL1608333 61091 11 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 3 0 3 5.6 COc1ccc(C=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)cc1OC nan
9581007 66044 2 None - 1 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1704074 66044 2 None - 1 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
16437205 38777 9 None -2 3 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 6 1 7 2.7 CCC1CCCCN1S(=O)(=O)c1ccc(NC(=O)c2nc(S(C)(=O)=O)ncc2Cl)cc1 nan
CHEMBL1407961 38777 9 None -2 3 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 6 1 7 2.7 CCC1CCCCN1S(=O)(=O)c1ccc(NC(=O)c2nc(S(C)(=O)=O)ncc2Cl)cc1 nan
1416931 30190 6 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1333032 30190 6 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
150149078 193123 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 193123 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
12533774 192297 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 192297 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634316 193121 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 193121 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
24792182 61858 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
CHEMBL1306983 61858 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
CHEMBL1616747 61858 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
57134579 169411 18 None - 1 Human 4.5 pIC50 = 4.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4169520 169411 18 None - 1 Human 4.5 pIC50 = 4.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145974046 169791 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 169791 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
13950957 164107 7 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 164107 7 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
9581012 66362 4 None - 1 Human 6.4 pIC50 = 6.4 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 415 5 2 6 3.3 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1718866 66362 4 None - 1 Human 6.4 pIC50 = 6.4 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 415 5 2 6 3.3 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccccc1 nan
6393553 53860 6 None 5 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 311 5 1 5 3.0 CC(NC(=O)/C(C#N)=C/c1ccc([N+](=O)[O-])o1)c1ccccc1 nan
CHEMBL1542492 53860 6 None 5 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 311 5 1 5 3.0 CC(NC(=O)/C(C#N)=C/c1ccc([N+](=O)[O-])o1)c1ccccc1 nan
145952039 169587 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 169587 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
2269231 52694 10 None 13 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1532025 52694 10 None 13 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
145959908 168841 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 168841 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
9581013 66484 4 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
CHEMBL1723578 66484 4 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
12533774 192297 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 192297 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
2841621 34473 7 None 2 3 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 4 0 4 3.8 CCOC(=O)C1=C(Cc2ccc(Cl)cc2)C(=O)c2ccccc2C1=O nan
CHEMBL1370183 34473 7 None 2 3 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 4 0 4 3.8 CCOC(=O)C1=C(Cc2ccc(Cl)cc2)C(=O)c2ccccc2C1=O nan
154634320 193389 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 193389 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
154634334 192204 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 192204 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145950576 169658 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
CHEMBL4173352 169658 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
56646802 74833 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
CHEMBL1914577 74833 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
5346366 48272 6 None 2 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1490915 48272 6 None 2 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
154634333 191994 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 191994 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
9581014 66770 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 337 4 2 6 1.5 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(N)=S nan
CHEMBL1734603 66770 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 337 4 2 6 1.5 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(N)=S nan
53258899 74842 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914586 74842 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
152243845 191678 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 191678 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
154634332 191906 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 191906 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634330 192731 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 192731 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
1214658 66247 9 None -4 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 392 4 0 5 5.5 COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1 nan
CHEMBL1713756 66247 9 None -4 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 392 4 0 5 5.5 COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1 nan
135399235 10906 60 None -18 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 10906 60 None -18 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 10906 60 None -18 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 10906 60 None -18 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
154634321 192776 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 192776 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634336 192847 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 192847 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634314 193388 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 193388 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145955278 169338 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4168406 169338 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
21337671 74839 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
CHEMBL1914583 74839 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
68324914 192510 38 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 192510 38 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
7424594 59763 4 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 5 1 3 5.3 O=C(/C=C/c1ccco1)c1ccc(NC(=O)C23CC4CC(CC(C4)C2)C3)cc1 nan
CHEMBL1596753 59763 4 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 5 1 3 5.3 O=C(/C=C/c1ccco1)c1ccc(NC(=O)C23CC4CC(CC(C4)C2)C3)cc1 nan
145959592 169129 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4164993 169129 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
6202912 54983 8 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 502 9 3 8 3.7 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC nan
CHEMBL1552304 54983 8 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 502 9 3 8 3.7 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC nan
1477048 36507 19 None 23 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 5 0 5 4.3 CN(C)/C=C/C(=O)c1ccc(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)cc1 nan
CHEMBL1386711 36507 19 None 23 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 5 0 5 4.3 CN(C)/C=C/C(=O)c1ccc(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)cc1 nan
5936070 40827 9 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 427 4 1 4 6.4 CC(=O)Nc1sc(/C(C#N)=C/c2ccc(Cl)c(Cl)c2)nc1-c1ccc(C)cc1 nan
CHEMBL1424929 40827 9 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 427 4 1 4 6.4 CC(=O)Nc1sc(/C(C#N)=C/c2ccc(Cl)c(Cl)c2)nc1-c1ccc(C)cc1 nan
154634323 191383 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 191383 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
151271218 192934 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 192934 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
1609318 49405 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 297 12 2 4 3.4 C=CCCCCCCCCc1nc(SCC(=O)O)n[nH]1 nan
CHEMBL1500763 49405 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 297 12 2 4 3.4 C=CCCCCCCCCc1nc(SCC(=O)O)n[nH]1 nan
282594 52121 17 None -2 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 331 2 0 3 3.7 CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1 nan
CHEMBL1526855 52121 17 None -2 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 331 2 0 3 3.7 CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1 nan
5334290 32695 10 None 7 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 7 1 4 5.6 CCN(CC)c1ccc(/C=C(/C#N)c2nc3cc(C)ccc3[nH]2)c(OC(C)C)c1 nan
CHEMBL1353925 32695 10 None 7 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 7 1 4 5.6 CCN(CC)c1ccc(/C=C(/C#N)c2nc3cc(C)ccc3[nH]2)c(OC(C)C)c1 nan
4189659 34826 5 None 6 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1372770 34826 5 None 6 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
2269231 52694 10 None 13 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1532025 52694 10 None 13 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
5733585 47744 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
CHEMBL1487024 47744 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
4189659 34826 5 None 6 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1372770 34826 5 None 6 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
53258795 74846 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 74846 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
660319 17775 96 None - 1 Human 4.2 pIC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
CHEMBL1173787 17775 96 None - 1 Human 4.2 pIC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
5722655 26882 6 None 17 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 8 1 4 5.6 CCCOc1cc(N(CC)CC)ccc1/C=C(/C#N)c1nc2cc(C)ccc2[nH]1 nan
CHEMBL1304179 26882 6 None 17 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 8 1 4 5.6 CCCOc1cc(N(CC)CC)ccc1/C=C(/C#N)c1nc2cc(C)ccc2[nH]1 nan
1024 23260 106 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 23260 106 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
154634318 192778 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 192778 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
53258898 74848 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914592 74848 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
154634334 192204 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 192204 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634330 192731 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 192731 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164610101 191654 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 191654 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
12138435 74832 29 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 74832 29 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
145951566 169544 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 169544 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
16103465 74843 2 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914587 74843 2 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
11957284 42710 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 3 2 8 5.0 Cc1nnc(NC(=O)c2sc3nc(-c4cccs4)cc(C(F)(F)F)c3c2N)s1 nan
CHEMBL1442537 42710 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 3 2 8 5.0 Cc1nnc(NC(=O)c2sc3nc(-c4cccs4)cc(C(F)(F)F)c3c2N)s1 nan
1542103 29256 24 None 2 3 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 418 4 0 6 4.2 Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1 nan
CHEMBL1325250 29256 24 None 2 3 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 418 4 0 6 4.2 Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1 nan
154634335 191262 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 191262 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
20992 203851 77 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 276 7 0 4 0.4 O=C1C=CC(=O)N1CCCCCCN1C(=O)C=CC1=O nan
CHEMBL567422 203851 77 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 276 7 0 4 0.4 O=C1C=CC(=O)N1CCCCCCN1C(=O)C=CC1=O nan
24789826 61839 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1307717 61839 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1616626 61839 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
1985027 39491 10 None 27 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 454 8 2 5 4.6 CCc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc1 nan
CHEMBL1413629 39491 10 None 27 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 454 8 2 5 4.6 CCc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc1 nan
12138434 74837 1 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
CHEMBL1914581 74837 1 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
164610101 191654 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 191654 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
1803281 26837 8 None 15 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 337 4 1 3 3.0 CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1 nan
CHEMBL1303807 26837 8 None 15 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 337 4 1 3 3.0 CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1 nan
798024 42198 5 None - 1 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 245 3 1 4 1.7 N#C/C(=C\c1ccc(N2CCCCC2)o1)C(N)=O nan
CHEMBL1437947 42198 5 None - 1 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 245 3 1 4 1.7 N#C/C(=C\c1ccc(N2CCCCC2)o1)C(N)=O nan
6201879 34161 16 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 456 8 2 6 4.0 COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1 nan
CHEMBL1367928 34161 16 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 456 8 2 6 4.0 COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1 nan
154634332 191906 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 191906 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145954727 169200 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 169200 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
5767616 26371 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 370 5 1 5 4.3 CCOc1ccc(N(C)c2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1 nan
CHEMBL1300169 26371 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 370 5 1 5 4.3 CCOc1ccc(N(C)c2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1 nan
152550147 192107 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 192107 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634322 192159 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 192159 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
1346847 27973 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
CHEMBL1312928 27973 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
10868388 168912 47 None - 1 Human 4.1 pIC50 = 4.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161599 168912 47 None - 1 Human 4.1 pIC50 = 4.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
1502520 41275 21 None -9 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
CHEMBL1428840 41275 21 None -9 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
3860640 156610 47 None -13 3 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 331 2 3 3 3.7 Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL394883 156610 47 None -13 3 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 331 2 3 3 3.7 Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1 nan
1231538 34291 29 None -1 3 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1368962 34291 29 None -1 3 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
4559736 41447 3 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 254 2 2 4 2.7 Nc1[nH]c2cc([N+](=O)[O-])ccc2c1-c1ccccn1 nan
CHEMBL1430125 41447 3 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 254 2 2 4 2.7 Nc1[nH]c2cc([N+](=O)[O-])ccc2c1-c1ccccn1 nan
326869 119588 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 119588 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634331 191327 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 191327 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
149708825 193170 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 193170 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
2277094 55790 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1560901 55790 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
1205881 42939 5 None 23 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1444708 42939 5 None 23 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
145958445 168910 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161574 168910 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145959306 169094 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4164556 169094 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
145949189 169516 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 169516 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
154634326 191871 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 191871 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
2732121 45302 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 306 3 0 4 3.6 CC(C)c1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1 nan
CHEMBL1464544 45302 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 306 3 0 4 3.6 CC(C)c1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1 nan
110720191 169236 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4166802 169236 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
3276705 53167 9 None - 1 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 521 8 2 6 4.3 CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccnc2Cl)c(NC(=O)c2cccnc2Cl)c1 nan
CHEMBL1536628 53167 9 None - 1 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 521 8 2 6 4.3 CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccnc2Cl)c(NC(=O)c2cccnc2Cl)c1 nan
6974996 78794 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 389 6 0 6 3.6 CC/N=C1\S/C(=C\c2cc(OC)c(N3CCCC3)cc2OC)C(=O)N1CC nan
CHEMBL1975147 78794 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 389 6 0 6 3.6 CC/N=C1\S/C(=C\c2cc(OC)c(N3CCCC3)cc2OC)C(=O)N1CC nan
154634327 191518 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 191518 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
18158890 30290 3 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL1333832 30290 3 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
1348329 33020 12 None 3 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1357976 33020 12 None 3 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
3804843 49020 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 321 1 1 6 2.1 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccsc3)C2C1 nan
CHEMBL1497386 49020 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 321 1 1 6 2.1 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccsc3)C2C1 nan
18158890 30290 3 None - 1 Human 5.0 pIC50 = 5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL1333832 30290 3 None - 1 Human 5.0 pIC50 = 5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
4659569 29103 101 None 4 5 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 None
CHEMBL1324 29103 101 None 4 5 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 None
5281081 214435 87 None - 1 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 None
CHEMBL953 214435 87 None - 1 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 None
2882 7991 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 7991 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 7991 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 7991 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 7991 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
2161 15505 121 None 154 3 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
Drug Central 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 None
CHEMBL1096 15505 121 None 154 3 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
Drug Central 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 None
2471 7526 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
427 7526 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
4837 7526 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
CHEMBL1072 7526 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
DB00887 7526 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
2882 7991 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 7991 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 7991 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 7991 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 7991 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
50294 224497 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
CHEMBL746 224497 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
DB00716 224497 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
3325 9118 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
44564 9118 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
9743 9118 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
CHEMBL1201266 9118 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
DB06794 9118 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
3325 9118 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
44564 9118 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
9743 9118 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
CHEMBL1201266 9118 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
DB06794 9118 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
2918 8985 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
2918 8985 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
3845 8985 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 8985 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
CHEMBL299155 8985 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 8985 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
DB11937 8985 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 8985 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
2471 7526 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
427 7526 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
4837 7526 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
CHEMBL1072 7526 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
DB00887 7526 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
118985385 8482 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
1258 8482 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
3440 8482 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
4839 8482 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
CHEMBL35 8482 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
DB00695 8482 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
2936 6873 0 None -3 4 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 436 20 3 5 5.0 CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO 20361937
56947016 6873 0 None -3 4 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 436 20 3 5 5.0 CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO 20361937
2920 9771 103 None -3388 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
54742459 9771 103 None -3388 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
8546 9771 103 None -3388 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
CHEMBL177880 9771 103 None -3388 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
2918 8985 126 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 8985 126 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 8985 126 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 8985 126 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
2918 8985 126 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 8985 126 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 8985 126 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 8985 126 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
135399235 10906 60 None -18 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2919 10906 60 None -18 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5722 10906 60 None -18 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
CHEMBL28079 10906 60 None -18 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2920 9771 103 None 3388 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
54742459 9771 103 None 3388 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
8546 9771 103 None 3388 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
CHEMBL177880 9771 103 None 3388 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
135399235 10906 60 None 18 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2919 10906 60 None 18 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5722 10906 60 None 18 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
CHEMBL28079 10906 60 None 18 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5280343 195054 124 None -8 12 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL1520590 195054 124 None -8 12 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL50 195054 124 None -8 12 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
2745687 7720 31 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 7720 31 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 7720 31 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
2745687 7720 31 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 7720 31 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 7720 31 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
135399235 10906 60 None - 1 Human 9.2 pEC50 = 9.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
2919 10906 60 None - 1 Human 9.2 pEC50 = 9.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
5722 10906 60 None - 1 Human 9.2 pEC50 = 9.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
CHEMBL28079 10906 60 None - 1 Human 9.2 pEC50 = 9.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
12138435 74832 29 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
CHEMBL1914576 74832 29 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
71733650 97618 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 97618 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
694463 94255 90 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL2333943 94255 90 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71733848 97636 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
CHEMBL2392179 97636 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
71733848 97636 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 97636 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
71733848 97636 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 97636 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
135399235 10906 60 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
2919 10906 60 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
5722 10906 60 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
CHEMBL28079 10906 60 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
71733845 97633 0 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 97633 0 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
4488 209800 110 None - 1 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 209800 110 None - 1 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
71733651 97619 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392162 97619 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733651 97619 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 97619 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71734940 97620 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm400587g
CHEMBL2392163 97620 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm400587g
118985385 8482 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 8482 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 8482 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 8482 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 8482 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 8482 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71733650 97618 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 97618 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71733843 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
CHEMBL2392174 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
CHEMBL2425818 97631 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
2920 9771 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 9771 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 9771 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 9771 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
2920 9771 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 9771 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 9771 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 9771 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71734944 97605 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
CHEMBL2392148 97605 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
71733653 97622 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392165 97622 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
2882 7991 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 7991 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 7991 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 7991 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 7991 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71734939 97601 1 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392144 97601 1 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733847 97635 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 97635 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
92934 176436 95 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in human HT29 cells by DMR assayAgonist activity at human GPR35 expressed in human HT29 cells by DMR assay
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
CHEMBL443738 176436 95 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in human HT29 cells by DMR assayAgonist activity at human GPR35 expressed in human HT29 cells by DMR assay
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
12403015 118273 1 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 300 2 4 4 0.8 O=C(O)c1cc(=O)c2c(ccc3c(=O)cc(C(=O)O)[nH]c32)[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL3277775 118273 1 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 300 2 4 4 0.8 O=C(O)c1cc(=O)c2c(ccc3c(=O)cc(C(=O)O)[nH]c32)[nH]1 10.1021/acs.jmedchem.6b01431
135399235 10906 60 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2919 10906 60 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
5722 10906 60 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
CHEMBL28079 10906 60 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
54676038 45497 77 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1466 45497 77 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
54676038 45497 77 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 45497 77 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
71733846 97634 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 97634 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71735030 97609 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
CHEMBL2392152 97609 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
71735030 97609 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
CHEMBL2392152 97609 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
71734942 97603 0 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392146 97603 0 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
271643 39554 70 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1414071 39554 70 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71733844 97632 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392175 97632 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71735034 97612 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392155 97612 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
10857978 122023 6 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
CHEMBL3347429 122023 6 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
137652009 164293 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 164293 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137652009 164293 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 164293 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733848 97636 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 97636 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
2295463 98996 34 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 98996 34 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
71733843 97631 6 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 97631 6 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 97631 6 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137657450 166374 3 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 166374 3 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137657450 166374 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 166374 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137657450 166374 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 166374 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71733651 97619 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 97619 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733939 97639 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
CHEMBL2392182 97639 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
137636652 162828 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4062531 162828 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
13950958 164407 4 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 164407 4 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
71733749 97629 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 97629 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71733749 97629 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 97629 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
13950958 164407 4 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 164407 4 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
4488 209800 110 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 209800 110 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
137653726 165455 3 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 165455 3 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733939 97639 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
CHEMBL2392182 97639 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
71735035 97613 0 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm400587g
CHEMBL2392156 97613 0 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm400587g
71733748 97628 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 97628 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733748 97628 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392171 97628 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733748 97628 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 97628 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733744 97624 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392167 97624 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733744 97624 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 97624 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733649 97617 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 97617 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733744 97624 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 97624 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
135399235 10906 60 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 10906 60 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 10906 60 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 10906 60 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71733845 97633 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 97633 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733845 97633 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 97633 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733649 97617 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 97617 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
135468531 97599 25 None - 0 Mouse 4.8 pEC50 = 4.8 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 97599 25 None - 0 Mouse 4.8 pEC50 = 4.8 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733743 97623 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
CHEMBL2392166 97623 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
5464105 64606 67 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
CHEMBL167055 64606 67 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
725495 72310 66 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 72310 66 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
725495 72310 66 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 72310 66 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
71733651 97619 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 97619 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137655259 165747 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096105 165747 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
11312 118295 63 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3278560 118295 63 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71733744 97624 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 97624 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
4921319 114238 58 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3183248 114238 58 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
135399235 10906 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 10906 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 10906 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 10906 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
137662152 166170 9 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 166170 9 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2920 9771 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
54742459 9771 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
8546 9771 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL177880 9771 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
2920 9771 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 9771 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 9771 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 9771 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71733649 97617 0 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 97617 0 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
657910 60226 53 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1600989 60226 53 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
71734943 97604 0 None - 1 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392147 97604 0 None - 1 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733847 97635 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 97635 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
71733746 97626 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 97626 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
2882 7991 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 7991 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 7991 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 7991 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 7991 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
71733653 97622 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392165 97622 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
3254949 122024 6 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3347474 122024 6 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
782693 165020 32 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4088382 165020 32 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71735036 97614 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 97614 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 97631 6 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 97631 6 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 97631 6 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
3870203 65104 55 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 200 2 2 6 0.9 O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL168276 65104 55 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 200 2 2 6 0.9 O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
135399235 10906 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 10906 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 10906 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 10906 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
71733842 97630 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392173 97630 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137658268 166441 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 166441 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
137658268 166441 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 166441 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
633803 122025 11 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347475 122025 11 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734941 97602 2 None - 1 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392145 97602 2 None - 1 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
10857978 122023 6 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
CHEMBL3347429 122023 6 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
71733747 97627 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
CHEMBL2392170 97627 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
71733749 97629 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392172 97629 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71733747 97627 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
CHEMBL2392170 97627 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
73294510 98994 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425823 98994 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
135468531 97599 25 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 97599 25 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
135468531 97599 25 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 97599 25 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733650 97618 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 97618 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
137646097 164679 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4084237 164679 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
71733749 97629 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 97629 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71735032 97610 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392153 97610 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
71733745 97625 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392168 97625 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
71733744 97624 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 97624 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733652 97621 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392164 97621 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
137652009 164293 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 164293 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137647862 164432 3 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4081445 164432 3 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
633803 122025 11 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347475 122025 11 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734946 97608 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
CHEMBL2392151 97608 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
2920 9771 103 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 9771 103 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 9771 103 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 9771 103 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
137662152 166170 9 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assayAgonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
CHEMBL4100677 166170 9 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assayAgonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
135468531 97599 25 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm4009373
CHEMBL2392141 97599 25 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm4009373
71733940 97640 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 97640 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
71733940 97640 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 97640 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
71733745 97625 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392168 97625 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733745 97625 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392168 97625 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
4488 209800 110 None - 1 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 209800 110 None - 1 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
1493 104866 76 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL273386 104866 76 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71733648 97616 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 97616 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
71733743 97623 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
CHEMBL2392166 97623 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
12138435 74832 29 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
CHEMBL1914576 74832 29 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
135399235 10906 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
2919 10906 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
5722 10906 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
CHEMBL28079 10906 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
71733749 97629 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 97629 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
137648473 164771 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 164771 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137648473 164771 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 164771 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733748 97628 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 97628 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
135399235 10906 60 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 10906 60 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 10906 60 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 10906 60 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
40119 91580 24 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assayAgonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assay
ChEMBL 312 1 1 6 1.2 O=C1c2ccccc2S(=O)(=O)c2cc(-c3nn[nH]n3)ccc21 10.1021/acsmedchemlett.7b00510
CHEMBL22336 91580 24 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assayAgonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assay
ChEMBL 312 1 1 6 1.2 O=C1c2ccccc2S(=O)(=O)c2cc(-c3nn[nH]n3)ccc21 10.1021/acsmedchemlett.7b00510
71735036 97614 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392157 97614 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735036 97614 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 97614 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71735036 97614 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 97614 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
2295463 98996 34 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 98996 34 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
135399235 10906 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 10906 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 10906 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 10906 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71735030 97609 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
CHEMBL2392152 97609 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
71733938 97638 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392181 97638 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
13950958 164407 4 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 164407 4 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
11872 114240 66 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3183545 114240 66 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
73294509 98993 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425822 98993 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733648 97616 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 97616 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
71733842 97630 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392173 97630 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
73294321 98992 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
CHEMBL2425820 98992 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
73294320 98991 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425819 98991 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
71733747 97627 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
CHEMBL2392170 97627 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
3325 9118 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
44564 9118 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
9743 9118 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
CHEMBL1201266 9118 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
DB06794 9118 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
2161 15505 121 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1021/acs.jmedchem.6b01431
CHEMBL1096 15505 121 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1021/acs.jmedchem.6b01431
71733848 97636 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 97636 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
13681 122022 67 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347428 122022 67 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL5285029 201054 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71734944 97605 0 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
CHEMBL2392148 97605 0 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
135399235 10906 60 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 10906 60 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 10906 60 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 10906 60 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71733846 97634 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 97634 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71733846 97634 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 97634 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
21236027 165766 4 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096323 165766 4 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
71733652 97621 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392164 97621 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
13950957 164107 7 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4077503 164107 7 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
21982642 97600 2 None - 1 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm400587g
CHEMBL2392142 97600 2 None - 1 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm400587g
71734946 97608 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
CHEMBL2392151 97608 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
71734946 97608 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
CHEMBL2392151 97608 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
71735036 97614 0 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 97614 0 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137646246 164514 3 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 164514 3 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 7991 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 7991 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 7991 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 7991 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 7991 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL5281778 200905 0 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71735031 97606 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392149 97606 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71735031 97606 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392149 97606 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
4659569 29103 101 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
CHEMBL1324 29103 101 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
71733845 97633 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 97633 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733940 97640 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 97640 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
73294508 7923 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
9742 7923 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
CHEMBL2425821 7923 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
137662152 166170 9 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 166170 9 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137662152 166170 9 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 166170 9 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2920 9771 103 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
54742459 9771 103 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
8546 9771 103 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
CHEMBL177880 9771 103 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
2920 9771 103 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
54742459 9771 103 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
8546 9771 103 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL177880 9771 103 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
71735036 97614 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 97614 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137646246 164514 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 164514 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
137646246 164514 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 164514 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 7991 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
741 7991 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
7608 7991 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL428880 7991 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
DB01003 7991 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
2882 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
2882 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 7991 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
9492 12241 43 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc([N+](=O)[O-])c(O)c1 10.1039/C2MD20210G
CHEMBL107513 12241 43 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc([N+](=O)[O-])c(O)c1 10.1039/C2MD20210G
11872 114240 66 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3183545 114240 66 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
4921319 114238 58 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3183248 114238 58 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71735032 97610 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392153 97610 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
3495594 23961 31 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
CHEMBL1256291 23961 31 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
13681 122022 67 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347428 122022 67 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
1231538 34291 29 None - 0 Human 6.3 pEC50 = 6.3 Binding
Antagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assayAntagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assay
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1368962 34291 29 None - 0 Human 6.3 pEC50 = 6.3 Binding
Antagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assayAntagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assay
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
5281081 214435 87 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL953 214435 87 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
137632988 163147 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 163147 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL5288015 201184 0 None - 1 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
6191 122020 49 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-] 10.1039/C2MD20210G
CHEMBL3347393 122020 49 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-] 10.1039/C2MD20210G
71733847 97635 0 None - 1 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 97635 0 None - 1 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
3254949 122024 6 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3347474 122024 6 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
73294319 98995 0 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425824 98995 0 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
135399235 10906 60 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 10906 60 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 10906 60 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 10906 60 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
118985385 8482 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 8482 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 8482 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 8482 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 8482 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 8482 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71733846 97634 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 97634 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71733844 97632 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392175 97632 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733846 97634 0 None - 1 Mouse 5.2 pEC50 = 5.2 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 97634 0 None - 1 Mouse 5.2 pEC50 = 5.2 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
5281081 214435 87 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL953 214435 87 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
137653726 165455 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 165455 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2918 8985 126 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
3845 8985 126 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
CHEMBL299155 8985 126 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
DB11937 8985 126 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
71734943 97604 0 None - 1 Rat 5.2 pEC50 = 5.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392147 97604 0 None - 1 Rat 5.2 pEC50 = 5.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
20486870 67871 5 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
CHEMBL1765162 67871 5 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
71733647 97615 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
CHEMBL2392158 97615 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
137653726 165455 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 165455 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
10800 170188 59 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL419564 170188 59 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71735033 97611 0 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm400587g
CHEMBL2392154 97611 0 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm400587g
71733746 97626 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 97626 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
137632988 163147 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 163147 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
2882 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
741 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
7608 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL428880 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
DB01003 7991 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
137632781 163066 3 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 163066 3 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137641148 163826 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4073902 163826 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
4659569 29103 101 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
CHEMBL1324 29103 101 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
11312 118295 63 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3278560 118295 63 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL5289040 201233 0 None - 1 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
135468531 97599 25 None - 0 Rat 5.1 pEC50 = 5.1 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 97599 25 None - 0 Rat 5.1 pEC50 = 5.1 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733647 97615 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
CHEMBL2392158 97615 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
10800 170188 59 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL419564 170188 59 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
5464105 64606 67 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
CHEMBL167055 64606 67 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
137654727 165524 3 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4093683 165524 3 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71733746 97626 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 97626 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
5066064 164151 6 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4078055 164151 6 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
3495594 23961 31 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
CHEMBL1256291 23961 31 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
71733648 97616 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 97616 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
137658472 166579 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 166579 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137658472 166579 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 166579 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71734945 97607 0 None - 1 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392150 97607 0 None - 1 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
10752 212596 100 None - 0 Human 4.0 pEC50 = 4.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL83294 212596 100 None - 0 Human 4.0 pEC50 = 4.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
137643561 164831 3 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4085935 164831 3 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
137632781 163066 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 163066 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137632781 163066 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 163066 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
54676038 45497 77 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 45497 77 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
135399235 10906 60 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 10906 60 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 10906 60 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 10906 60 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2882 7991 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 7991 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 7991 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 7991 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 7991 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71733940 97640 0 None - 1 Rat 6.0 pEC50 = 6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 97640 0 None - 1 Rat 6.0 pEC50 = 6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
5281855 209622 109 None - 0 Human 7.0 pIC50 = 7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 209622 109 None - 0 Human 7.0 pIC50 = 7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
10752 212596 100 None - 0 Human 4.0 pIC50 = 4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL83294 212596 100 None - 0 Human 4.0 pIC50 = 4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL5289040 201233 0 None - 1 Human 6.0 pIC50 = 6.0 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
2745687 7720 31 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 7720 31 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 7720 31 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
725495 72310 66 None - 0 Human 6.0 pIC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 72310 66 None - 0 Human 6.0 pIC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
16103462 74844 19 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 74844 19 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
153273978 202705 4 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 202705 4 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 202705 4 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
694463 94255 90 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL2333943 94255 90 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
135399235 10906 60 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 10906 60 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 10906 60 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 10906 60 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
4488 209800 110 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 209800 110 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
137652009 164293 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 164293 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137635873 162651 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 539 6 1 6 5.0 O=C(Nc1ccc2nc([S+]([O-])Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL4060393 162651 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 539 6 1 6 5.0 O=C(Nc1ccc2nc([S+]([O-])Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
271643 39554 70 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1414071 39554 70 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
137636652 162828 3 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4062531 162828 3 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
137655259 165747 3 None - 0 Human 4.8 pIC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096105 165747 3 None - 0 Human 4.8 pIC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
5280343 195054 124 None - 31 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 195054 124 None - 31 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 195054 124 None - 31 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
411 9371 92 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 9371 92 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 9371 92 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
137647862 164432 3 None - 0 Human 5.8 pIC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4081445 164432 3 None - 0 Human 5.8 pIC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
137647638 164417 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 537 6 1 6 6.5 CC(Sc1nc2ccc(NC(=O)c3ccccc3C(=O)N3CCOCC3)cc2s1)c1ccc(Cl)cc1 10.1016/j.bmcl.2016.12.012
CHEMBL4081331 164417 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 537 6 1 6 6.5 CC(Sc1nc2ccc(NC(=O)c3ccccc3C(=O)N3CCOCC3)cc2s1)c1ccc(Cl)cc1 10.1016/j.bmcl.2016.12.012
5215 9165 132 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 9165 132 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 9165 132 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
2745687 7720 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
9741 7720 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
CHEMBL1708510 7720 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
2745687 7720 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 7720 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 7720 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
5281672 63328 121 None - 0 Human 5.7 pIC50 = 5.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 63328 121 None - 0 Human 5.7 pIC50 = 5.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
782693 165020 32 None - 0 Human 4.7 pIC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4088382 165020 32 None - 0 Human 4.7 pIC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
137653726 165455 3 None - 0 Human 7.6 pIC50 = 7.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 165455 3 None - 0 Human 7.6 pIC50 = 7.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
657910 60226 53 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1600989 60226 53 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
2286812 36239 35 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
CHEMBL1384502 36239 35 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
2286812 36239 35 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 36239 35 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
137646097 164679 3 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4084237 164679 3 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
5281605 212511 114 None - 0 Human 4.6 pIC50 = 4.6 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 212511 114 None - 0 Human 4.6 pIC50 = 4.6 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
137658268 166441 3 None - 0 Human 5.5 pIC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 166441 3 None - 0 Human 5.5 pIC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
135403802 33304 56 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 33304 56 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
5328791 211763 64 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 211763 64 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
137646246 164514 3 None - 0 Human 7.5 pIC50 = 7.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 164514 3 None - 0 Human 7.5 pIC50 = 7.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
137648473 164771 3 None - 0 Human 6.5 pIC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 164771 3 None - 0 Human 6.5 pIC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
21236027 165766 4 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096323 165766 4 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
13950957 164107 7 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4077503 164107 7 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
137632781 163066 3 None - 0 Human 6.4 pIC50 = 6.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 163066 3 None - 0 Human 6.4 pIC50 = 6.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
5491415 82067 19 None - 0 Human 6.4 pIC50 = 6.4 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 82067 19 None - 0 Human 6.4 pIC50 = 6.4 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
2918 8985 126 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
3845 8985 126 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
CHEMBL299155 8985 126 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
DB11937 8985 126 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
CHEMBL5285029 201054 0 None - 1 Human 6.4 pIC50 = 6.4 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
73157 202138 30 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 202138 30 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
1231538 34291 29 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1368962 34291 29 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
137657450 166374 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 166374 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
3884 51272 77 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 51272 77 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
137641148 163826 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4073902 163826 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL5285029 201054 0 None - 1 Human 8.3 pIC50 = 8.3 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
20486870 67871 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
CHEMBL1765162 67871 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
2286812 36239 35 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 36239 35 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
137646699 164516 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 555 6 1 7 4.6 O=C(Nc1ccc2nc(S(=O)(=O)Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL4082295 164516 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 555 6 1 7 4.6 O=C(Nc1ccc2nc(S(=O)(=O)Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL5281778 200905 0 None - 1 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
13950958 164407 4 None - 1 Human 7.3 pIC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 164407 4 None - 1 Human 7.3 pIC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
2745687 7720 31 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 7720 31 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 7720 31 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
137654727 165524 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4093683 165524 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137632988 163147 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 163147 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL5288015 201184 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
5346366 48272 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1490915 48272 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
137658472 166579 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 166579 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL5288015 201184 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
137662152 166170 9 None - 1 Human 8.1 pIC50 = 8.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 166170 9 None - 1 Human 8.1 pIC50 = 8.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
5066064 164151 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4078055 164151 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL5281778 200905 0 None - 1 Human 8.0 pIC50 = 8.0 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5289040 201233 0 None - 1 Human 8.0 pIC50 = 8.0 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
137643561 164831 3 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4085935 164831 3 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
71733843 97631 6 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 97631 6 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 97631 6 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL5288015 201184 0 None - 1 Human 7.8 pKd = 7.8 Binding
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5281778 200905 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71733843 97631 6 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 97631 6 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 97631 6 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 97631 6 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 97631 6 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 97631 6 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 97631 6 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 97631 6 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 97631 6 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL5289040 201233 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5285029 201054 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
73294508 7923 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
9742 7923 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
CHEMBL2425821 7923 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
71733748 97628 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392171 97628 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733848 97636 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
CHEMBL2392179 97636 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
73294320 98991 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425819 98991 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
73294321 98992 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
CHEMBL2425820 98992 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
73294319 98995 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425824 98995 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
145971442 169806 0 None - 1 Human 8.0 pKi = 8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.2c00461
CHEMBL4175848 169806 0 None - 1 Human 8.0 pKi = 8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.2c00461
2920 9771 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 9771 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 9771 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 9771 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71735035 97613 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm4009373
CHEMBL2392156 97613 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm4009373
2920 9771 103 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 9771 103 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 9771 103 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 9771 103 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71733650 97618 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392161 97618 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71733648 97616 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm4009373
CHEMBL2392159 97616 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm4009373
71733746 97626 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392169 97626 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
21982642 97600 2 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm4009373
CHEMBL2392142 97600 2 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm4009373
71733652 97621 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392164 97621 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
2920 9771 103 None - 1 Human 7.8 pKi = 7.8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 9771 103 None - 1 Human 7.8 pKi = 7.8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 9771 103 None - 1 Human 7.8 pKi = 7.8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 9771 103 None - 1 Human 7.8 pKi = 7.8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733842 97630 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392173 97630 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733847 97635 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm4009373
CHEMBL2392178 97635 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm4009373
71733743 97623 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm4009373
CHEMBL2392166 97623 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm4009373
71734941 97602 2 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392145 97602 2 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734943 97604 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392147 97604 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734940 97620 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm4009373
CHEMBL2392163 97620 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm4009373
71733749 97629 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392172 97629 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
73294510 98994 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425823 98994 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735036 97614 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392157 97614 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733846 97634 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm4009373
CHEMBL2392177 97634 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm4009373
2920 9771 103 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 9771 103 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 9771 103 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 9771 103 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733647 97615 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm4009373
CHEMBL2392158 97615 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm4009373
2882 7991 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 7991 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 7991 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 7991 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 7991 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
2745687 7720 31 None - 1 Human 6.6 pKi = 6.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
9741 7720 31 None - 1 Human 6.6 pKi = 6.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
CHEMBL1708510 7720 31 None - 1 Human 6.6 pKi = 6.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
71733651 97619 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392162 97619 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733940 97640 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm4009373
CHEMBL2392183 97640 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm4009373
71733653 97622 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392165 97622 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
71734945 97607 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392150 97607 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
154634314 193388 0 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acsmedchemlett.2c00461
CHEMBL4878979 193388 0 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acsmedchemlett.2c00461
2882 7991 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 7991 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 7991 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 7991 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 7991 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
71734939 97601 1 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392144 97601 1 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
118985385 8482 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 8482 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 8482 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 8482 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 8482 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 8482 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71735031 97606 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392149 97606 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733845 97633 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392176 97633 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
1024 23260 106 None - 1 Human 6.5 pKi = 6.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acsmedchemlett.2c00461
CHEMBL1235421 23260 106 None - 1 Human 6.5 pKi = 6.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acsmedchemlett.2c00461
13950958 164407 4 None - 1 Human 6.5 pKi = 6.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acsmedchemlett.2c00461
CHEMBL4081238 164407 4 None - 1 Human 6.5 pKi = 6.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acsmedchemlett.2c00461
71734944 97605 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm4009373
CHEMBL2392148 97605 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm4009373
4488 209800 110 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 209800 110 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
71733937 97637 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 379 6 2 5 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(OCC2CC2)cc1 10.1021/jm4009373
CHEMBL2392180 97637 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 379 6 2 5 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(OCC2CC2)cc1 10.1021/jm4009373
54676038 45497 77 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 45497 77 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
2286812 36239 35 None - 1 Human 8.4 pKi = 8.4 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
CHEMBL1384502 36239 35 None - 1 Human 8.4 pKi = 8.4 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
71733649 97617 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392160 97617 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733747 97627 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
CHEMBL2392170 97627 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
135399235 10906 60 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2919 10906 60 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
5722 10906 60 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
CHEMBL28079 10906 60 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2745687 7720 31 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 7720 31 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 7720 31 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
73294509 98993 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425822 98993 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735033 97611 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm4009373
CHEMBL2392154 97611 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm4009373
71735032 97610 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392153 97610 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
71733843 97631 6 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 97631 6 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 97631 6 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733744 97624 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392167 97624 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
2295463 98996 34 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 98996 34 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
137662152 166170 9 None - 1 Human 7.3 pKi = 7.3 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
CHEMBL4100677 166170 9 None - 1 Human 7.3 pKi = 7.3 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
71733939 97639 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm4009373
CHEMBL2392182 97639 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm4009373
326869 119588 5 None - 1 Human 8.2 pKi = 8.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acsmedchemlett.2c00461
CHEMBL3306990 119588 5 None - 1 Human 8.2 pKi = 8.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acsmedchemlett.2c00461
135399235 10906 60 None - 1 Human 6.2 pKi = 6.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
2919 10906 60 None - 1 Human 6.2 pKi = 6.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
5722 10906 60 None - 1 Human 6.2 pKi = 6.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
CHEMBL28079 10906 60 None - 1 Human 6.2 pKi = 6.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
12138435 74832 29 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL1914576 74832 29 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71734942 97603 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392146 97603 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71735030 97609 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
CHEMBL2392152 97609 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
71735034 97612 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392155 97612 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71734946 97608 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
CHEMBL2392151 97608 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
2286812 36239 35 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 36239 35 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
2920 9771 103 None - 1 Human 8.1 pKi = 8.1 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 9771 103 None - 1 Human 8.1 pKi = 8.1 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 9771 103 None - 1 Human 8.1 pKi = 8.1 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 9771 103 None - 1 Human 8.1 pKi = 8.1 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733938 97638 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392181 97638 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733745 97625 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392168 97625 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
2920 9771 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 9771 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 9771 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 9771 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733844 97632 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392175 97632 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
92934 176436 95 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
CHEMBL443738 176436 95 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
4488 209800 110 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 None
CHEMBL63323 209800 110 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 None
118985385 8482 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
1258 8482 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
3440 8482 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
4839 8482 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
CHEMBL35 8482 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
DB00695 8482 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
2882 7991 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 7991 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 7991 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 7991 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 7991 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
54676038 45497 77 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O None
CHEMBL1466 45497 77 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O None
2745687 7720 31 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
9741 7720 31 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
CHEMBL1708510 7720 31 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
2745687 7720 31 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 7720 31 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 7720 31 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
73294508 7923 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932
9742 7923 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932
CHEMBL2425821 7923 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932